Certified by Founder Lodge
Ceretype Neuromedicine, Inc.
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $0
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ceretype has pioneered the integration of fMRI into therapeutic applications in neuropsychiatry. Our uniquely scalable platform makes targeted biomarkers accessible, delivering actionable ins
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 05 ,2024 | Seed | Undisclosed Amount |
Leafy Tunnel
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
CREAO AI | $10,000,000 | (Apr 21, 2026)
TraqCheck | $8,000,000 | (Apr 21, 2026)
Antioch | $8,500,000 | (Apr 21, 2026)
ScreenPoint Medical | $14,000,000 | (Apr 21, 2026)
Ultralight | $9,300,000 | (Apr 21, 2026)
